Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptorγ ligands in vitro and in vivo

Clinical Cancer Research

Volumn 14, Issue 13, 2008, Pages 4045-4052

  Hsu, Ming Chuan ^a   Huang, Chao Cheng ^b   Chang, Hui Chiu ^a,c   Hu, Tsung Hui ^b   Hung, Wen Chun ^c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE HYDROLASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN JAB1; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG; COPS5 PROTEIN, HUMAN; LIGAND; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HEPATITIS B; HEPATITIS C; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ADULT; AGED; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; LIVER TUMOR; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PEPTIDE HYDROLASES; PPAR GAMMA;

EID: 48249136165     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-5040     Document Type: Article

References (28)

1. Claret FX. Hibi M, Dhut S, Toda T. Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 1996; 383:453-7.
2. Seeger M, Kraft R, Ferrell K, Bech-Otschir D, Dumdey R, Schade R. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J 1998;12:469-78.
3. Wei N. Tsuge T, Serino G, et al. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr Biol1998;8:919-22
4. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature1999;398:160-5.
5. Bech-Otschir D, Kraft R, Huang X, et al. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 2001;20: 1630-9.
6. Wan M, Cao X, Wu Y, et al. Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation. EMBO Rep 2002;3:171-6.
7. Bae MK, Ahn MY, Jeong JW, et al. Jab1 interacts directly with HlF-1 a and regulates its stability. J Biol Chem 2002;277:9-12.
8. Tomoda K, Kato J Y, Tatsumi E, Takahashi T, Matsuo Y Yoneda-Kato N. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Blood 2005;105:775-83.
9. Kouvaraki MA, Korapati AL, Rassidakis GZ, et al. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. Cancer Res 2006;66:8581-9.
10. Fukomoto A, Tomoda K, Yoneda-Kato N, Nakajima Y Kato JY. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines. FEBS Lett 2006;580: 5836-40.
11. Esteva FJ, Sahin AA, Rassidakis GZ, et al. Jun activation domain binding protein 1 expression is associated with low p27(Kip1) levels in node-negative breast cancer. Clin Cancer Res 2003;9:5652-9.
12. Green S. PPAR: a mediator of peroxisome proliferator action. Mutat Res 1995;333:101-9.
13. Compbell IW. The clinical significance of PPARγ agonism. Curr Mol Med 2005;5:349-63.
14. Murphy GJ, Holder JC. PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 2000;21:469-74.
15. Koga H, Sakisaka S, Harada M, et al Involvement of p21 (WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Hepatology 2001;33:1087-97.
16. Koga H, Harada M, Ohtsubo MS, et al. Troglitazone induces p27Kip1- associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Hepatology 2003;37:1086-96.
17. Hung WC, Chang HC, Pan MR, Lee TH, Chuang LY Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells. Mol Pharmacol 2000;58:1398-403.
18. Hsu MC, Chang HC, Hung WC. HER-2/neu transcriptionally activates Jab1 expression via the AKT/β- catenin pathway in breast cancer cells. Endocr Relat Cancer 2007;14:655-67.
19. Hsu MC, Chang HC, Hung WC. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J Biol Chem 2006;281:4718-25.
20. Chang HC, Cho CY Hung WC. Silencing of the me-tastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res 2006;66:8413-20.
21. Sugawara A, Uruno A, Kudo M, et al. Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-© via an interaction with Spl in vascular smooth muscle cells. J Biol Chem 2002;277:9676-83.
22. Hong J, Samudio I, Liu S. Abdelrahim M, Safe S. Peroxisome proliferator- activated receptor -γ-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins Endocrinology 2004 145:5774-85.
23. Liu J. Wang H. ZuoY Farmer SR. Functional interaction between peroxisome proliferator-activated receptor γ and β-catenin. Mol Cell Biol 2006;26:5827-37
24. Patil MA, Gutgemann I, Zhang J, et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 2005;26:2050-7.
25. Tanaka Y Kanai F, Ichimura T, et al. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 2006;25:633-42.
26. Giannitrapani L, Soresi M, La Spada E, Cervello M, DAIessandro N, Montalto G. Sex hormones and risk of liver tumor Ann N Y Acad Sci 2006;1089:228-36
27. Callige M, Kieffer I, Richard-Foy H. CSN5/Jab1 is involved in ligand- dependent degradation of estrogen receptor a by the proteasome. Mol Cell Biol 2005:25: 4349-58.
28. Chauchereau A, Georgiakaki M. Perrin-Wolff M. Milgrom E, Loosfelt H. JAB1 interacts with both the progesterone receptor and SRC-1. J Biol Chem 2000; 275:8540-8.